BEYOND Pilot Study

NCT00893217 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis
Relapsing-Remitting

Interventions

DRUG: Betaseron (Interferon beta-1b, BAY86-5046)
DRUG: Betaseron (Interferon beta-1b, BAY86-5046)

Sponsor

Bayer